AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Giving high doses of omega-3, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can lead to significant reductions in triglycerides. In a study where subjects were given 25 grams of EPA and DHA daily, triglycerides decreased from about 100 to 75, showcasing the impactful lowering effect. Apart from triglycerides, LDL cholesterol levels also saw a pronounced reduction from 250 to 230, demonstrating a positive impact on heart health.
Additionally, omega-3, especially EPA, showed antiplatelet properties by prolonging bleeding time in subjects. This translates to improved blood flow and could potentially lower the risk of blood clot formation. However, in some individuals, such as a college student in the study, a marked drop in platelet count was observed, necessitating discontinuation of the omega-3 diet for safety reasons.
It was noted that in studies with high concentrations of EPA and DHA, particularly in higher doses like four grams a day, LDL cholesterol levels might increase. This phenomenon was attributed to potential effects of DHA on LDL receptors, slowing down their removal of LDL particles, leading to elevated blood levels. The findings indicated a nuanced impact on cholesterol levels depending on dose and composition.
A study named Vascepa, administered four grams a day of EPA ethyl ester, demonstrated heart-healthy benefits in patients with elevated triglyceride levels. With subjects on statin drugs but still exhibiting triglyceride levels between 150 and 500, Vascepa showed reductions in triglycerides and maintained low LDL cholesterol levels. This study focused on individuals with existing heart disease or risk factors like diabetes, showcasing the potential of EPA in improving cardiovascular health.
Taking omega-3 supplements, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can significantly reduce the risk of cardiovascular events, including heart attacks. Even at a low dose of 850 milligrams per day, these supplements showed a 20% reduction in heart attacks. The study, compared to the well-known REDUCE-IT trial, demonstrated the benefits of omega-3 supplements for cardiovascular health.
Measuring blood omega-3 levels is crucial for assessing one's omega-3 status. The Omega-3 Index, which reflects the levels of EPA and DHA in red blood cells, serves as a stable long-term marker of omega-3 status. It is recommended that doctors prioritize measuring omega-3 levels in patients similar to cholesterol monitoring to ensure optimal cardiovascular health.
Pharmaceutical-grade omega-3 supplements, such as epinova, offer a different formulation as free fatty acids compared to ethyl esters found in products like Vascepa and Lovaza. The free fatty acid form facilitates direct absorption without the need for enzymatic conversion in the gut, enhancing bioavailability and effectiveness. However, the availability of pure EPA as a free fatty acid in supplements is expected to be more accessible in the future.
The ongoing STRENGTH trial, comparable to the REDUCE-IT trial but using a free fatty acid formulation, is anticipated to provide further insights into the benefits of omega-3 supplements. Scheduled to conclude in October next year, this study aims to evaluate the efficacy of omega-3 supplements, potentially offering a more successful alternative to existing formulations. The results are expected to be released at the American Heart Association in 2022, shedding light on the impact of omega-3 supplementation on cardiovascular health.
Contrary to misconceptions, omega-6 fatty acids, primarily derived from plant seed oils like canola and safflower, play a beneficial role in reducing the risk of heart disease, stroke, and diabetes. While omega-6 levels have been on the rise, studies have shown a significant correlation between higher linoleic acid intake and improved cardiovascular health outcomes. Understanding the balance between omega-3 and omega-6 fatty acids is essential for maintaining optimal health.
Omega-3 levels in the blood take about four months to stabilize after a change in supplementation, reflecting the turnover rate of red blood cells. Regular monitoring of omega-3 status through red blood cell tests ensures an accurate assessment of one's omega-3 levels, guiding dietary adjustments for long-term cardiovascular health benefits. Choosing a reliable omega-3 supplement and maintaining consistent intake can lead to sustained improvements in cardiovascular well-being.
In this episode, Bill Harris, Ph.D. in human nutrition and expert on omega-3 fatty acids, sets the table by clearly defining the families of fatty acids (saturated, monounsaturated, polyunsaturated) before diving into the current landscape of polyunsaturated fat (omega-6 and omega-3) with a particular focus on EPA and DHA (the two main elements of fish oil supplements). Bill gives a historical overview, updates us on the latest science related to the health benefits, and provides plenty of insights as to how we should think about increasing our EPA and DHA intake.
We discuss:
Learn more: https://peterattiamd.com/ Show notes page for this episode: https://peterattiamd.com/billharris Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on Facebook | Twitter | Instagram.
Listen to all your favourite podcasts with AI-powered features
Listen to the best highlights from the podcasts you love and dive into the full episode
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
Listen to all your favourite podcasts with AI-powered features
Listen to the best highlights from the podcasts you love and dive into the full episode